Alteration of adhesion molecule expression and cellular polarity in hepatocellular carcinoma

Histopathology

Volumn 51, Issue 4, 2007, Pages 528-538

  Cao, Y ^a   Chang, H ^a   Li, L ^b   Cheng, R C ^c   Fan, X N ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b Kunming First People Hospital   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Adherens junctions; Desmosomes; Liver; Tight junction; Tumour

Indexed keywords

CELL ADHESION MOLECULE; DESMOCOLLIN; DESMOGLEIN; DESMOPLAKIN; PLAKOPHILIN; PROTEIN DERIVATIVE; SYMPLEKIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; CONTROLLED STUDY; DESMOSOME; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR CELL; WESTERN BLOTTING;

ADENOMA; ADHERENS JUNCTIONS; CARCINOMA, HEPATOCELLULAR; CELL ADHESION MOLECULES; CELL POLARITY; CELL TRANSFORMATION, NEOPLASTIC; DESMOGLEINS; DESMOPLAKINS; DESMOSOMES; HUMANS; LIVER; LIVER NEOPLASMS; NUCLEAR PROTEINS; PLAKOPHILINS;

EID: 34548809689     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02820.x     Document Type: Article

References (33)

1. Lecuit T. Adhesion remodeling underlying tissue morphogenesis. Trends Cell Biol. 2005 15 34 42.
2. Garrod D, Chidgey M, North A. Desmosomes: differentiation, development, dynamics and disease. Curr. Opin. Cell Biol. 1996 8 670 678.
3. Keon BH, Schäfer S, Kuhn C, Grund C, Franke WW. Symplekin, a novel type of tight junction plaque protein. J. Cell Biol. 1996 134 1003 1018.
4. Birchmeier W. E-cadherin as a tumor invasion suppressor gene. BioEssays 1995 17 97 99.
5. Perl A-K, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998 392 190 193.
6. Slagie BL, Zhou Y-Z, Birchmeier W, Scorsone KA. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology 1993 18 757 762.
7. Kanai Y, Ushijima S, Hui A-M et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer 1997 71 355 359.
8. de la Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. U.S.A. 1998 95 8847 8851.
9. Miyoshi Y, Iwao K, Nagasawa Y et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 1998 58 2524 2527.
10. Kozyraki R, Scoazec J-Y, Flejou J-F et al. Expression of cadherins and α-catenin in primary epithelial tumours of the liver. Gastroenterology 1996 110 1137 1149.
11. Inagawa S, Itabashi M, Adachi S et al. Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin. Cancer Res. 2002 8 450 456.
12. Ihara A, Koizumi H, Hashizume R, Uchikoshi T. Expression of epithelial cadherin and α- and β-catenin in nontumoral livers and hepatocellular carcinomas. Hepatology 1996 23 1441 1447.
13. Stamatoglou SC, Hughes RC. Cell adhesion molecules in liver function and pattern formation. FASEB J. 1994 8 420 427.
14. Cao Y, Schlag PM, Karsten U. Immunodetection of epithelial mucin (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and Sialosyl-Tn) in benign and malignant lesions of colon epithelium: apolar localization correspond to the malignant transformation. Virchows Arch. 1997 431 159 166.
15. Hubbard AL, Wall DA, Ma A. Isolation of rat hepatocyte plasma membranes: I. Presence of the three major domains. J. Cell Biol. 1983 96 217 229.
16. Cao Y, Merling A, Crocker PR, Schwartz-Albiez R. Differential expression of β-galactoside α2,6 sialyltransferase (ST6Gal.I) and sialoglycans in normal and cirrhotic liver and hepatocellular carcinomas. Lab. Invest. 2002 82 1515 1524.
17. Racila E, Euhus D, Weiss AJ et al. Detection and characterization of carcinoma cells in the blood. Proc. Natl Acad. Sci. U.S.A. 1998 95 4589 4594.
18. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995 22 983 993.
19. Ishak KG, Anthony PP, Sobin LH. Histological typing of tumours of the liver. In WHO eds. International histological classification of tumours, 2nd edn. Geneva : World Health Organization, 1994 11 17.
20. Kojiro M. Pathology of hepatocellular carcinoma. In Okuda K, Tabor E eds. Liver cancer. New York : Churchill Livingstone, 1997 165 187.
21. Wei Y, Van Nhieu JT, Prigent S et al. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002 36 692 701.
22. Cagatay T, Ozturk M. P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells. Oncogene 2002 21 7971 7980.
23. Liu J, Lian Z, Han S et al. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 2006 25 1008 10017.
24. Taniguchi T, Miyazaki M, Miyashita Y, Arima T, Ozawa M. Identification of regions of alpha-catenin required for desmosome organization in epithelial cells. Int. Mol. Med. 2005 16 1003 1008.
25. Willott E, Balda MS, Fanning AS, Jameson B, Itallie CV, Anderson JM. The tight junction protein ZO-1 is homologous to the Drosophila discs-large tumor suppressor protein of septate junctions. Proc. Natl Acad. Sci. U.S.A. 1993 90 7834 7838.
26. Zhong Y, Enomoto K, Tobika H, Konishi Y, Satoh M, Mori M. Sequential decrease in tight junctions as revealed by 7H6 tight junction-associated protein during rat hepatocarcinogenesis. Jpn J. Cancer Res. 1994 85 351 356.
27. Cao Y, Karsten U, Otto G, Bannasch P. Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions. Virchows Arch. 1999 434 503 509.
28. Demelehner MP, Schäfer S, Grund C, Franke WW. Continual assembly of half-desmosomal structures in the absence of cell contacts and their frustrated endocytosis: a coordinated sisyphus cycle. J. Cell Biol. 1995 131 745 760.
29. Schmelz M, Duden R, Cowin P, Franke WW. A constitutive transmembrane glycoprotein of Mr 165,000 (desmoglein) in epidermal and non-epidermal desmosomes: I. Biochemical identification of the polypeptide. Eur. J. Cell Biol. 1986 42 177 183.
30. Schäfer S, Stumpp S, Franke WW. Immunological identification and characterization of the desmosomal cadherin Dsg2 in coupled and uncoupled epithelial cells and in human tissues. Differentiation 1996 60 99 108.
31. Nuber UA, Schäfer S, Stehr S, Rackwitz H-R, Franke WW. Patterns of desmocollin synthesis in human epithelia: immunolocalization of desmocollins 1 and 3 in special epithelia and in cultured cells. Eur. J. Cell Biol. 1996 71 1 13.
32. Heid HW, Schmidt A, Zimbelmann R et al. Cell type-specific desmosomal plaque proteins of the plakoglobin family: plakophilin 1 (band 6 protein). Differentiation 1994 58 113 131.
33. Mertens C, Kuhn C, Franke WW. Plakophilins 2a and 2b: constitutive proteins of dual location in the karyoplasm and the desmosomal plaque. J. Cell Biol. 1996 135 1009 1025.